可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Yun DD,Alpert JS. Acute coronary syndromes [J]. Cardiology, 1997, 88(3): 223-237.
[2] Yokoyama T, Miyauchi K, Kurata T, et al.Effect of probucol on neointimal thickening in a stent porcine restenosis model[J]. Jpn Heart J, 2004,45(2): 305-313.
[3] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性心肌梗死诊断和治疗指南[J]. 中华心血管病杂志,2001,29(12):710-725.
[4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412.
[5] Bing H, Wang J, Zhang C. et al. Positive correlation between in vivo oxidized LDL and LDL immune complex[J]. Clin Biochem, 2004,37(1):72-75.
[6] 罗兰,王为忠,管文贤,等.冠心病患者血液流变学和氧化低密度脂蛋白变化及其相关性分析[J]. 心脏杂志, 2004,16(1):62-63,66.
[7] Asmis R, Begley JG, Jelk J,et al. Lipoprotein aggregation protects human monocytederived macrophages from OxLDLinduced cytotoxicity [J]. J Lipid Res,2005,46(6): 1124-1132.
[8] 刘安恒,李兰荪,张荣庆,等.急性冠状动脉综合征患者血清IL-8水平的检测及其意义[J]. 心脏杂志, 2005, 17(2):142-144.
[9] Divecha H, Sattar N, Rumley A,et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with noninflammatory control subjects: relevance of systemic inflammation[J]. Clin Sci(Lond), 2005, 109(2): 171-176.
[10]Chait A, Han CY, Oram JF,et al. Thematic review series: The immune system and atherogenesis. Lipoproteinassociated inflammatory proteins: markers or mediators of cardiovascular disease? [J] J Lipid Res,2005,46(3): 389-403.
[11]Saku K, Zhang B, Jimi S, et al. Highdensity lipoprotein and apolipoprotein AI deficiency induced by combination therapy with probucol and bezafibrate[J]. Eur J Clin Pharmacol, 1995, 48 (3-4) : 209-215.
[12]朱冰坡,范利,李小鹰, 等. 普罗布考对老年下肢动脉硬化症患者内皮舒张功能的影响[J]. 中华老年心脑血管病杂志, 2005,7(1): 17-19.